Bacitracin EP Impurity C
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

Bacitracin EP Impurity C

● 在庫あり

カタログ番号:VE0026806
CAS番号:N/A
分子式:C64H99N17O16S
分子量:1394.7 g/mol

に関する追加情報

親薬物

Bacitracin

IUPAC名

4,10-anhydro[N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazol-4-yl]carbonyl]-L-leucyl-D-α-glutamyl-L-valyl-L-lysyl-D-ornithyl-L-valyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-L-asparagine]

Pharmacopeial Synonyms

Bacitracin D3; Bacitracin C1a

同義語

N/A

説明

Bacitracin EP Impurity C is an identified process-related and degradation impurity observed during bacitracin manufacturing and stability studies. It exhibits a distinct chromatographic retention relative to the bacitracin major components and is routinely detected by validated HPLC-UV and LC-MS assays as part of impurity profiling. Structural elucidation relies on high-resolution mass spectrometry and NMR following isolation. Its presence, origin, and levels are monitored under pharmacopoeial and ICH impurity control strategies to ensure product quality. Control measures include optimization of fermentation parameters, purification sequence, and stability-indicating analytical methods with defined identification, qualification, and specification thresholds.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url